Smith & Nephew plc Sets New 1-Year High at $73.25 (SNN)
Smith & Nephew plc (NYSE:SNN) set a new 52-week high on Tuesday, Analyst Ratings Net reports. The company traded as high as $73.25 and last traded at $73.17, with a volume of 130,580 shares. The stock had previously closed at $72.45.
A number of research firms have recently commented on SNN. Analysts at Goldman Sachs Group Inc. downgraded shares of Smith & Nephew plc from a “neutral” rating to a “sell” rating in a research note to investors on Tuesday. Separately, analysts at Bank of America Corp. upgraded shares of Smith & Nephew plc from a “neutral” rating to a “buy” rating in a research note to investors on Thursday, December 19th. Finally, analysts at Canaccord Genuity initiated coverage on shares of Smith & Nephew plc in a research note to investors on Monday, December 9th. They set a “buy” rating and a $77.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $77.00.
Smith & Nephew plc has a 52 week low of $52.52 and a 52 week high of $73.23. The stock has a 50-day moving average of $70. and a 200-day moving average of $64.12. The company has a market cap of $13.160 billion and a P/E ratio of 24.27.
Smith & Nephew plc is a global medical devices business operating in the orthopedics, endoscopy and advanced wound management markets.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.